Literature DB >> 9767284

Narrowband ultraviolet B (TL-01) phototherapy for psoriasis: which incremental regimen?

N J Wainwright1, R S Dawe, J Ferguson.   

Abstract

Narrowband (311-313 nm) ultraviolet B phototherapy with the Philips TL-01 lamp is used increasingly in the treatment of psoriasis with little information available on the optimum irradiation regimen. We compared a high and a low incremental dose regimen in 20 patients with symmetrical chronic plaque psoriasis using a randomized half body study and thrice weekly exposures. Paired trunk, leg and arm plaques of psoriasis were scored blind prior to and at each treatment for scaling, erythema and induration. Patients were treated to clearance or minimal residual activity and followed up until relapse. The low increment regimen achieved a 10% reduction in the median cumulative dose to clearance (16,401 vs. 18,246 mJ/cm2) with one extra treatment in 50% of the patients. However, the duration of treatment (median 53.5 days) was identical for both regimens except for one patient because there were 50% fewer episodes of erythema requiring postponement of treatment with the low increment regimen. We now favour the low increment regimen for phototherapy in our psoriasis population.

Entities:  

Mesh:

Year:  1998        PMID: 9767284     DOI: 10.1046/j.1365-2133.1998.02403.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

1.  [Comparison of the minimal erythema dose for narrowband UV-B and broad spectrum UV-B using a new UV hand-held device].

Authors:  M Lehnen; M Koppermann; A Korber; S Grabbe; J Dissemond
Journal:  Hautarzt       Date:  2005-03       Impact factor: 0.751

2.  Pretreatment with an Aerosol Foam Containing Calcipotriene and Betamethasone Strongly Improves the Efficacy of Narrow-Band UVB Phototherapy.

Authors:  Gaetano Licata; Mariachiara Arisi; Marina Venturini; Mariateresa Rossi; Cesare Tomasi; Irene Calzavara-Pinton; Piergiacomo Calzavara-Pinton
Journal:  Dermatol Ther (Heidelb)       Date:  2022-08-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.